ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

VAL Valirx Plc

3.05
-0.05 (-1.61%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Valirx Plc LSE:VAL London Ordinary Share GB00BLH13C52 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.05 -1.61% 3.05 3.00 3.10 3.15 3.05 3.10 1,785,708 13:41:03
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Medical Laboratories 0 -2.37M -0.0262 -1.16 2.75M
Valirx Plc is listed in the Medical Laboratories sector of the London Stock Exchange with ticker VAL. The last closing price for Valirx was 3.10p. Over the last year, Valirx shares have traded in a share price range of 3.05p to 14.75p.

Valirx currently has 90,174,156 shares in issue. The market capitalisation of Valirx is £2.75 million. Valirx has a price to earnings ratio (PE ratio) of -1.16.

Valirx Share Discussion Threads

Showing 26126 to 26147 of 29350 messages
Chat Pages: Latest  1054  1053  1052  1051  1050  1049  1048  1047  1046  1045  1044  1043  Older
DateSubjectAuthorDiscuss
23/1/2023
15:08
Someone mentioned 2 weeks ago this would not fall below 12p .
francoismyname
23/1/2023
14:38
Theorem has done real damage to Suzanne Dilly's credibility..I sympathise ..hope for a better future for val.
baldrick1
21/1/2023
08:53
Here's another VC site so the timescale VAL are within with THX is pretty normal:https://www.indeed.com/hire/c/info/series-a-funding"How long does Series A funding last?Series A funding is meant to last between six months and two years to guide development. Business owners need a clear plan for how much money they will need in the Series A round to sustain their business throughout the product launch. How long does Series B funding last?Series B funding can last a few months or a few years, depending on what it's being used for. It is meant to last long enough to oversee major scaling and new product launches until the business can sustain its growth through its own revenue."
wulber
21/1/2023
08:40
Who is to doubt Suzy and why on earth would she lie and damage her position, livelihood and reputation?https://visible.vc/blog/startup-funding-stages/Google VC funding and you'll find 12-18 months is the norm, some shorter and some longer timeframes:"As a general rule of thumb, funding should last somewhere between 12 and 18 months."
wulber
21/1/2023
01:14
Wulber TRx has been 'on' according to SD since Nov 2021.
carlisle44
20/1/2023
23:38
Nice bullish candle there stig and Macd turning up too.....
wulber
20/1/2023
23:17
THX couldn't raise z flag never mind the credit they need. Have you been living under a rock!!
tburns
20/1/2023
21:36
Lots of assumptions there Porky and you could be miles out. THX still on according to SD plus, what else could THX handle with the legacy assets plus the 201 other handles? Again with the lab, we have no idea behind closed doors what is going on at this juncture and there could be nice cash flow sooner than we think! GLA
wulber
20/1/2023
11:23
Fair play Porky. You summed up everything that is wrong with VAL, how were go there, where we are likely to go in the shirt term and what Dilly needs to do to rectify the problem. You did that in 10 paragraphs, please send it to here as would take her 10 weeks to come to the same assessment, if she had the business acumen to do so.
tburns
20/1/2023
09:22
How can he when he’s on strike as a postman obviously is the hours that he posts ha.
412069
20/1/2023
09:13
You should run the company..you got all the solutions..why not? ;)
baldrick1
20/1/2023
05:13
Buying spree, you must be kidding - Have you read the CENKOS report?

The company has ZERO focus on revenue it only knows how to spend hence why it wants resolution 4 passed by shareholders now to give it an open mandate to issue another 30m of shares at anytime it wants to for further cash.

As it stands as expected their cash burn increased by 210k last year. With this raise they will have enough cash runway to circa April 2024. This is a positive.

The business plan has changed yet again, they not only want to set one lab up to do own and third party work (no lab revenues forecast for 2023) they want to acquire others. This will be costly and further raises will be required for that so expect more dilution. They have identified 4 targets yet no experience of running one lab profitably let alone 4.

To set up lab 1 they forecast 400k for equipment and other one off costs and 200k of running costs to the end of this year for rent and a lab manager and assistant.

There is nothing in the CENKOS report detailed for sales and marketing so not sure how they will tender for contracts. They forecast no revenue this year BUT it will save some money bringing current outsourced work inhouse. Lab running costs going forward will be 300k. CENKOS state the lab will likely be in Medicity Nottingham and they will have lots of business contacts nearby. I think its totally naive to think lab contracts will just land on them - they will need to win contracts in a competitive space and that will require good sales and marketing imo.

Should the THX deal land Q1 before end of March 23 this would give them a further £1.3m in 2023 year resulting in extending the cash runway through to end of 2024.

IMO the risk profile has gone up materially. My price target is now 5p by June.

After the results for 22 are out April 23? IF the THX deal is NOT sorted by then I think the share price will materially fall knowing that a further discounted placing will be on its way. Suzy was right to do this small raise now on the authority they currently have from shareholders and push for a new resolution at the AGM because if she didn't it would be at a materially discounted level. When i say she was right, i mean from the perspective of protecting the business and not leaving until the eleventh hour, not what is best for shareholders.

Where this has all gone wrong imo is giving their prime asset 201 away to a skint start up that cant raise cash. Making it exclusive and then when timelines missed rather than pull the exclusive issued and start looking for an alternative partner they extend exclusivity on an indefinite basis. Further because they have no focus on revenue (cash raises are too easy)they don't even collect the monthly support fees from them.

We will see how this unfolds going forward, those adding at 11p i think would be wise to flip on any spikes especially if THX comes across the line. Otherwise its dilution all the way imo.

One factor that could change fortunes is if they can win decent sized new lab contracts that pay or they can monetise 301 or kings but i don't see that in 2023 i think its far too soon, looking at late 24/25 earliest imo. This rests now on 201 being done to extend the cash runway otherwise they have no way of gaining decent revenue other than to squeeze shareholders for more - jury is out.

Finally, one other scenario that could turn this around, get Kevin out and the NED Martin Lampshire (does he add any value?) replace with Adam. Demote Suzy to head sciences. Bring in another NED that will invest and show some commercial acumen and support Adam. Get Stella to put her hand in her pocket and buy shares.

Good Luck

porky9
19/1/2023
18:59
Guess its good as why would their broker send out anything else. Bottom found l hope and held up well - now need the meat on the bones to propel the share price back up - expect a buying spree asap.
wulber
19/1/2023
08:35
What is the content of the report good or bad?
baldrick1
19/1/2023
08:13
Cenkos just released latest research note on valirx
jasonpugh
18/1/2023
09:44
01. 👌
jasonpugh
17/1/2023
22:33
201 👌
jasonpugh
17/1/2023
19:51
01👌
jasonpugh
16/1/2023
11:40
Lab sorted, the next carrots going to be 301 kings or 201 take you pick.
Or 4p Franco’s

412069
14/1/2023
21:59
Yeah, but what a great decision and purchase - look at the medium term new income! Plus money in the bank.
wulber
14/1/2023
18:44
For those saying we have only dropped a penny with this fundraise, you're fooling yourselves. It's the reason we have gone from 18p to 11p. Those who knew this was coming have been selling down happy in the knowledge Dilly was planning another funding exercise. No wonder she turns a funny shade of scarlet on all those zoom calls. I'm beginning to think this is just another AIM lifestyle company. She's a rubbish CEO making a living on shareholders backs.
sooty snipes
14/1/2023
13:26
I think it tells you the commitments we're already in the bag.
paddyfool
Chat Pages: Latest  1054  1053  1052  1051  1050  1049  1048  1047  1046  1045  1044  1043  Older

Your Recent History

Delayed Upgrade Clock